Trevi Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 07:30 ET
|
Trevi Therapeutics
NEW HAVEN, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™...
Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25
March 18, 2021 16:05 ET
|
Trevi Therapeutics
NEW HAVEN, Conn., March 18, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™...